Shopping Cart
Remove All
Your shopping cart is currently empty
Medifoxamine (LG 152) is a selective non-monoamine oxidase inhibitor that exhibits antidepressant activity through inhibition of 5 HT reuptake.Medifoxamine preferentially inhibits dopamine reuptake.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $100 | - | In Stock | |
| 5 mg | $247 | - | In Stock | |
| 10 mg | $372 | - | In Stock | |
| 25 mg | $668 | - | In Stock | |
| 50 mg | $939 | - | In Stock | |
| 100 mg | $1,220 | - | In Stock | |
| 1 mL x 10 mM (in DMSO) | $272 | - | In Stock |
| Description | Medifoxamine (LG 152) is a selective non-monoamine oxidase inhibitor that exhibits antidepressant activity through inhibition of 5 HT reuptake.Medifoxamine preferentially inhibits dopamine reuptake. |
| In vivo | Medifoxamine (200, 500, 750, and 1000 mg; oral) was well tolerated and exhibited a first-order linear pharmacokinetic profile. It underwent rapid absorption and peak plasma concentrations were achieved about 1.0 h after administration. Thereafter the elimination profile was biphasic with a mean terminal half-life less than 3 hours. We found a linear relationship (r = 0.80) between administered dose and AUC values for the four doses. High values were obtained for the apparent volumes of distribution and the plasma clearance.[4] |
| Synonyms | Medifoxamina, LG-152, LG152, LG 152 |
| Molecular Weight | 257.33 |
| Formula | C16H19NO2 |
| Cas No. | 32359-34-5 |
| Smiles | CN(C)CC(Oc1ccccc1)Oc1ccccc1 |
| Relative Density. | 1.076g/cm3 |
| Color | White |
| Appearance | Liquid |
| Storage | Pure form: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 90 mg/mL (349.75 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 3.3 mg/mL (12.82 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.